supporting new cancer treatment

Intertek helped in the development of second-generation breast cancer treatment by resolving the new drug's hold from the US Food and Drug Administration (FDA).

Have a similar issue? Get in touch.
Share this story:

expertise that makes progress possible

During clinical trials for this important treatment the FDA had concerns about the immune response in the study samples, with an extraordinarily high rate of positives. As a result, the trials were placed on hold. Intertek was able to independently test the data and help to assess and solve the issue.

Industry-leading services

We provide contract pharmaceutical and biopharmaceutical laboratory services, supply chain audits and regulatory guidance, supporting drug development and production.

From early discovery through to late-stage clinical studies, our specialist teams provide essential knowledge, discretion, and capability where and when our clients need it.

science-based expertise

Our experts work with you at every stage of development, providing consistently high quality and flexible services that enable better treatments around the world and marketplace advantages for healthcare companies.

Bioanalytical Services
Pharmaceutical Product Development Consulting
Immunochemistry Services
Formulation Development

talk to our experts

Whether you have a complex issue to resolve, or already know exactly what you need, we'll help you make progress.

Just fill in your details below, and a subject matter expert will get in touch to see how we could help.